Global Onychomycosis (Tinea Unguium) Drug Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

世界の爪真菌症(爪白癬)薬産業:成長傾向・競合分析2019-2025

◆タイトル:Global Onychomycosis (Tinea Unguium) Drug Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
◆商品コード:DATA908B14440
◆調査・発行会社:QYResearch
◆発行日:2019年8月20日
◆ページ数:116
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:機械・装置
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥604,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD11,200 ⇒換算¥1,209,600見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

※本調査レポートでは、世界の爪真菌症(爪白癬)薬市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。爪真菌症(爪白癬)薬の種類別には、経口薬、外用薬に、用途別には、18歳未満、18〜50歳、50歳以上に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・爪真菌症(爪白癬)薬の種類別市場規模:経口薬、外用薬
・爪真菌症(爪白癬)薬の用途別市場規模:18歳未満、18〜50歳、50歳以上
・爪真菌症(爪白癬)薬の地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Johnson and Johnson、GSK、Novartis、Pfizer、Valeant Pharma、Kaken Pharmaceutical、Galderma、Xiuzheng Pharmaceutical、Letai、Qilu Pharmaceutical
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...

Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.

USA is the largest consumption place, with a consumption market share nearly 33.14% in 2016. Following USA, Europe is the second largest consumption place with the consumption market share of 23.66%.Market competition is intense. Johnson & Johnson, GSK, Novartis, Pfizer, Valeant PharmaKaken Pharmaceutical are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The Onychomycosis (Tinea Unguium) Drug market was valued at 2708.8 Million US$ in 2018 and is projected to reach 3331.8 Million US$ by 2025, at a CAGR of 3.1% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Onychomycosis (Tinea Unguium) Drug.

This study focuses on the production side and consumption side of Onychomycosis (Tinea Unguium) Drug, presents the global Onychomycosis (Tinea Unguium) Drug market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
In terms of production side, this report researches the Onychomycosis (Tinea Unguium) Drug capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Onychomycosis (Tinea Unguium) Drug by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

This report includes the following manufacturers; we can also add the other companies as you want.
Johnson and Johnson
GSK
Novartis
Pfizer
Valeant Pharma
Kaken Pharmaceutical
Galderma
Xiuzheng Pharmaceutical
Letai
Qilu Pharmaceutical

Market Segment by Product Type
Oral Medication
External Medicine

Oral medication is the largest segment, had a share over 75% in 2018.

Market Segment by Application
Age under 18
Age 18-50
Age above 50

The most proportion of consumer is in Age 18-50, and the market share was 82.66% in 2016.

Key Regions split in this report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Onychomycosis (Tinea Unguium) Drug status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Onychomycosis (Tinea Unguium) Drug manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Onychomycosis (Tinea Unguium) Drug are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Type
1.3.2 Oral Medication
1.3.3 External Medicine
1.4 Market Segment by Application
1.4.1 Global Onychomycosis (Tinea Unguium) Drug Market Share by Application (2019-2025)
1.4.2 Age under 18
1.4.3 Age 18-50
1.4.4 Age above 50
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Onychomycosis (Tinea Unguium) Drug Production Value 2014-2025
2.1.2 Global Onychomycosis (Tinea Unguium) Drug Production 2014-2025
2.1.3 Global Onychomycosis (Tinea Unguium) Drug Capacity 2014-2025
2.1.4 Global Onychomycosis (Tinea Unguium) Drug Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size CAGR of Key Regions
2.2.2 Global Onychomycosis (Tinea Unguium) Drug Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Onychomycosis (Tinea Unguium) Drug Capacity by Manufacturers
3.1.2 Global Onychomycosis (Tinea Unguium) Drug Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturers (2014-2019)
3.2.2 Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Onychomycosis (Tinea Unguium) Drug Market Concentration Ratio (CR5 and HHI)
3.3 Onychomycosis (Tinea Unguium) Drug Price by Manufacturers
3.4 Key Manufacturers Onychomycosis (Tinea Unguium) Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Onychomycosis (Tinea Unguium) Drug Market
3.6 Key Manufacturers Onychomycosis (Tinea Unguium) Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Oral Medication Production and Production Value (2014-2019)
4.1.2 External Medicine Production and Production Value (2014-2019)
4.2 Global Onychomycosis (Tinea Unguium) Drug Production Market Share by Type
4.3 Global Onychomycosis (Tinea Unguium) Drug Production Value Market Share by Type
4.4 Onychomycosis (Tinea Unguium) Drug Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Onychomycosis (Tinea Unguium) Drug Consumption by Application

6 Production by Regions
6.1 Global Onychomycosis (Tinea Unguium) Drug Production (History Data) by Regions 2014-2019
6.2 Global Onychomycosis (Tinea Unguium) Drug Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Onychomycosis (Tinea Unguium) Drug Production Growth Rate 2014-2019
6.3.2 United States Onychomycosis (Tinea Unguium) Drug Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Onychomycosis (Tinea Unguium) Drug Import & Export
6.4 Europe
6.4.1 Europe Onychomycosis (Tinea Unguium) Drug Production Growth Rate 2014-2019
6.4.2 Europe Onychomycosis (Tinea Unguium) Drug Production Value Growth Rate 2014-2019
6.4.3 Key Players in Europe
6.4.4 Europe Onychomycosis (Tinea Unguium) Drug Import & Export
6.5 China
6.5.1 China Onychomycosis (Tinea Unguium) Drug Production Growth Rate 2014-2019
6.5.2 China Onychomycosis (Tinea Unguium) Drug Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Onychomycosis (Tinea Unguium) Drug Import & Export
6.6 Japan
6.6.1 Japan Onychomycosis (Tinea Unguium) Drug Production Growth Rate 2014-2019
6.6.2 Japan Onychomycosis (Tinea Unguium) Drug Production Value Growth Rate 2014-2019
6.6.3 Key Players in Japan
6.6.4 Japan Onychomycosis (Tinea Unguium) Drug Import & Export
6.7 Other Regions
6.7.1 South Korea
6.7.2 India
6.7.3 Southeast Asia

7 Onychomycosis (Tinea Unguium) Drug Consumption by Regions
7.1 Global Onychomycosis (Tinea Unguium) Drug Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Onychomycosis (Tinea Unguium) Drug Consumption by Type
7.2.2 North America Onychomycosis (Tinea Unguium) Drug Consumption by Application
7.2.3 North America Onychomycosis (Tinea Unguium) Drug Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Onychomycosis (Tinea Unguium) Drug Consumption by Type
7.3.2 Europe Onychomycosis (Tinea Unguium) Drug Consumption by Application
7.3.3 Europe Onychomycosis (Tinea Unguium) Drug Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Consumption by Type
7.4.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug Consumption by Application
7.4.3 Asia Pacific Onychomycosis (Tinea Unguium) Drug Consumption by Regions
7.4.4 China
7.4.5 Japan
7.4.6 South Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Onychomycosis (Tinea Unguium) Drug Consumption by Type
7.5.2 Central & South America Onychomycosis (Tinea Unguium) Drug Consumption by Application
7.5.3 Central & South America Onychomycosis (Tinea Unguium) Drug Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption by Type
7.6.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption by Application
7.6.3 Central & South America Onychomycosis (Tinea Unguium) Drug Consumption by Countries
7.6.4 Turkey
7.6.5 GCC Countries
7.6.6 Egypt
7.6.7 South Africa

8 Company Profiles
8.1 Johnson and Johnson
8.1.1 Johnson and Johnson Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Onychomycosis (Tinea Unguium) Drug
8.1.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
8.1.5 Johnson and Johnson Recent Development
8.2 GSK
8.2.1 GSK Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Onychomycosis (Tinea Unguium) Drug
8.2.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
8.2.5 GSK Recent Development
8.3 Novartis
8.3.1 Novartis Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Onychomycosis (Tinea Unguium) Drug
8.3.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
8.3.5 Novartis Recent Development
8.4 Pfizer
8.4.1 Pfizer Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Onychomycosis (Tinea Unguium) Drug
8.4.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
8.4.5 Pfizer Recent Development
8.5 Valeant Pharma
8.5.1 Valeant Pharma Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Onychomycosis (Tinea Unguium) Drug
8.5.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
8.5.5 Valeant Pharma Recent Development
8.6 Kaken Pharmaceutical
8.6.1 Kaken Pharmaceutical Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Onychomycosis (Tinea Unguium) Drug
8.6.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
8.6.5 Kaken Pharmaceutical Recent Development
8.7 Galderma
8.7.1 Galderma Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Onychomycosis (Tinea Unguium) Drug
8.7.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
8.7.5 Galderma Recent Development
8.8 Xiuzheng Pharmaceutical
8.8.1 Xiuzheng Pharmaceutical Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Onychomycosis (Tinea Unguium) Drug
8.8.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
8.8.5 Xiuzheng Pharmaceutical Recent Development
8.9 Letai
8.9.1 Letai Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Onychomycosis (Tinea Unguium) Drug
8.9.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
8.9.5 Letai Recent Development
8.10 Qilu Pharmaceutical
8.10.1 Qilu Pharmaceutical Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Onychomycosis (Tinea Unguium) Drug
8.10.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
8.10.5 Qilu Pharmaceutical Recent Development

9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production Forecast 2019-2025
9.1.2 Global Onychomycosis (Tinea Unguium) Drug Production Value Forecast 2019-2025
9.2 Onychomycosis (Tinea Unguium) Drug Production and Production Value Forecast by Regions
9.2.1 Global Onychomycosis (Tinea Unguium) Drug Production Value Forecast by Regions
9.2.2 Global Onychomycosis (Tinea Unguium) Drug Production Forecast by Regions
9.3 Onychomycosis (Tinea Unguium) Drug Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.3.5 Other Regions
9.4 Forecast by Type
9.4.1 Global Onychomycosis (Tinea Unguium) Drug Production Forecast by Type
9.4.2 Global Onychomycosis (Tinea Unguium) Drug Production Value Forecast by Type

10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Countries 2019-2025
10.4.2 France
10.4.3 UK
10.4.4 Italy
10.4.5 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Regions 2019-2025
10.5.2 Japan
10.5.3 South Korea
10.5.4 India
10.5.5 Australia
10.5.6 Indonesia
10.5.7 Thailand
10.5.8 Malaysia
10.5.9 Philippines
10.5.10 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Country 2019-2025
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Countries 2019-2025
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Onychomycosis (Tinea Unguium) Drug Sales Channels
11.2.2 Onychomycosis (Tinea Unguium) Drug Distributors
11.3 Onychomycosis (Tinea Unguium) Drug Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

List of Tables and Figures

Figure Onychomycosis (Tinea Unguium) Drug Product Picture
Table Onychomycosis (Tinea Unguium) Drug Key Market Segments
Table Major Manufacturers Onychomycosis (Tinea Unguium) Drug Covered in This Report
Table Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Onychomycosis (Tinea Unguium) Drug Sales Market Shar by Type 2014-2025
Figure Oral Medication Figures
Table Major Manufacturers of Oral Medication
Figure External Medicine Figures
Table Major Manufacturers of External Medicine
Table Global Onychomycosis (Tinea Unguium) Drug Market Share by Application 2019-2025 (K Units)
Figure Age under 18 Use Case
Figure Age 18-50 Use Case
Figure Age above 50 Use Case
Figure Onychomycosis (Tinea Unguium) Drug Report Years Considered
Figure Global Onychomycosis (Tinea Unguium) Drug Production Value Growth Rate 2014-2025 (Million US$)
Figure Global Onychomycosis (Tinea Unguium) Drug Production 2014-2025 (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Capacity 2014-2025 (K Units)
Table Key Manufacturers Onychomycosis (Tinea Unguium) Drug Capacity (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Price 2014-2025 (USD/Unit)
Table Global Onychomycosis (Tinea Unguium) Drug Market Size of Key Regions (Million USD) & (K Units)
Table Global Onychomycosis (Tinea Unguium) Drug Growth Rate of Key Regions 2019-2025 (Million USD)
Table Global Onychomycosis (Tinea Unguium) Drug Market Share for of Regions 2019-2025 (K Units)
Table Market Top Trends
Table Global Onychomycosis (Tinea Unguium) Drug Capacity by Manufacturers (2014-2019) (K Units)
Table Global Onychomycosis (Tinea Unguium) Drug Capacity Market Share by Manufacturers (2014-2019)
Table Global Onychomycosis (Tinea Unguium) Drug Production by Manufacturers (2014-2019) (K Units)
Table Global Onychomycosis (Tinea Unguium) Drug Production Share by Manufacturers (2014-2019)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Share by Manufacturers in 2018
Table Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers (2014-2019)
Figure Onychomycosis (Tinea Unguium) Drug Value Share by Manufacturers in 2018
Table Global Onychomycosis (Tinea Unguium) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Onychomycosis (Tinea Unguium) Drug Price by Manufacturers 2014-2019 (USD/Unit)
Table Key Manufacturers Onychomycosis (Tinea Unguium) Drug Plants/Factories Distribution
Table Key Manufacturers Onychomycosis (Tinea Unguium) Drug Area Served
Table Date of Key Manufacturers Enter into Onychomycosis (Tinea Unguium) Drug Market
Table Key Manufacturers Onychomycosis (Tinea Unguium) Drug Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Oral Medication Production and Production Value (2014-2019) (K Units) & (Million US$)
Table Global External Medicine Production and Production Value (2014-2019) (K Units) & (Million US$)
Table Global Onychomycosis (Tinea Unguium) Drug Production by Type (2014-2019) (K Units)
Table Global Onychomycosis (Tinea Unguium) Drug Production Share by Type (2014-2019)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Market Share by Type (2014-2019)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Market Share by Type in 2018
Table Global Onychomycosis (Tinea Unguium) Drug Production Value by Type (2014-2019) (Million US$)
Table Global Onychomycosis (Tinea Unguium) Drug Production Value Share by Type (2014-2019)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Value Market Share by Type (2014-2019)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Value Market Share by Type in 2018
Table Onychomycosis (Tinea Unguium) Drug Ex-factory Price by Type 2014-2019 (USD/Unit)
Table Global Onychomycosis (Tinea Unguium) Drug Consumption by Application (2014-2019) (K Units)
Table Global Onychomycosis (Tinea Unguium) Drug Consumption Share by Application (2014-2019)
Figure Global Consumption Onychomycosis (Tinea Unguium) Drug Market Share by Application (2014-2019)
Table Global Onychomycosis (Tinea Unguium) Drug Production by Regions 2014-2019 (K Units)
Table Global Onychomycosis (Tinea Unguium) Drug Production Market Share by Regions 2014-2019
Figure Global Onychomycosis (Tinea Unguium) Drug Production Market Share by Regions 2014-2019
Figure Global Onychomycosis (Tinea Unguium) Drug Production Market Share by Regions in 2018
Table Global Onychomycosis (Tinea Unguium) Drug Production Value by Regions 2014-2019 (Million USD)
Table Global Onychomycosis (Tinea Unguium) Drug Production Value Market Share by Regions 2014-2019
Figure Global Onychomycosis (Tinea Unguium) Drug Production Value Market Share by Regions 2014-2019
Figure Global Onychomycosis (Tinea Unguium) Drug Production Value Market Share by Regions in 2018
Table United States Onychomycosis (Tinea Unguium) Drug Production and Value 2014-2019 (K Units) & (Million USD)
Figure United States Onychomycosis (Tinea Unguium) Drug Production Growth Rate 2014-2019 (K Units)
Figure United States Onychomycosis (Tinea Unguium) Drug Production Value Growth Rate 2014-2019 (Million USD)
Table United States Onychomycosis (Tinea Unguium) Drug Import & Export (K Units)
Table Europe Onychomycosis (Tinea Unguium) Drug Production and Value 2014-2019 (K Units) & (Million USD)
Figure Europe Onychomycosis (Tinea Unguium) Drug Production Growth Rate 2014-2019 (K Units)
Figure Europe Onychomycosis (Tinea Unguium) Drug Production Value Growth Rate 2014-2019 (Million USD)
Table Europe Onychomycosis (Tinea Unguium) Drug Import & Export (K Units)
Table China Onychomycosis (Tinea Unguium) Drug Production and Value 2014-2019 (K Units) & (Million USD)
Figure China Onychomycosis (Tinea Unguium) Drug Production Growth Rate 2014-2019 (K Units)
Figure China Onychomycosis (Tinea Unguium) Drug Production Value Growth Rate 2014-2019 (Million USD)
Table China Onychomycosis (Tinea Unguium) Drug Import & Export (K Units)
Table Japan Onychomycosis (Tinea Unguium) Drug Production and Value 2014-2019 (K Units) & (Million USD)
Figure Japan Onychomycosis (Tinea Unguium) Drug Production Growth Rate 2014-2019 (K Units)
Figure Japan Onychomycosis (Tinea Unguium) Drug Production Value Growth Rate 2014-2019 (Million USD)
Table Japan Onychomycosis (Tinea Unguium) Drug Import & Export (K Units)
Table Global Onychomycosis (Tinea Unguium) Drug Consumption by Regions 2014-2019 (K Units)
Table Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Regions 2014-2019
Figure Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Regions 2014-2019
Figure Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Regions in 2018
Figure North America Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Table North America Onychomycosis (Tinea Unguium) Drug Consumption by Type (2014-2019) (K Units)
Figure North America Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type in 2018
Table North America Onychomycosis (Tinea Unguium) Drug Consumption by Application (2014-2019) (K Units)
Figure North America Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application in 2018
Table North America Onychomycosis (Tinea Unguium) Drug Consumption by Countries (2014-2019) (K Units)
Figure North America Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Countries in 2018
Figure United States Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Canada Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Mexico Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Europe Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Table Europe Onychomycosis (Tinea Unguium) Drug Consumption by Type (2014-2019) (K Units)
Figure Europe Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type in 2018
Table Europe Onychomycosis (Tinea Unguium) Drug Consumption by Application (2014-2019) (K Units)
Figure Europe Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application in 2018
Table Europe Onychomycosis (Tinea Unguium) Drug Consumption by Countries (2014-2019) (K Units)
Figure Europe Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Countries in 2018
Figure Germany Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure France Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure UK Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Italy Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Russia Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Asia Pacific Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug Consumption by Type (2014-2019) (K Units)
Figure Asia Pacific Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type in 2018
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug Consumption by Application (2014-2019) (K Units)
Figure Asia Pacific Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application in 2018
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug Consumption by Regions (2014-2019) (K Units)
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Countries (2014-2019)
Figure China Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Japan Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure South Korea Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure India Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Australia Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Indonesia Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Thailand Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Malaysia Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Philippines Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Vietnam Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Central & South America Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Table Central & South America Onychomycosis (Tinea Unguium) Drug Consumption by Type (2014-2019) (K Units)
Figure Central & South America Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type in 2018
Table Central & South America Onychomycosis (Tinea Unguium) Drug Consumption by Application (2014-2019) (K Units)
Figure Central & South America Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application in 2018
Table Central & South America Onychomycosis (Tinea Unguium) Drug Consumption by Countries (2014-2019) (K Units)
Figure Central & South America Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Countries
Figure Brazil Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption by Type (2014-2019) (K Units)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type in 2018
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption by Application (2014-2019) (K Units)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application in 2018
Figure Turkey Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure GCC Countries Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Egypt Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure South Africa Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate (2014-2019) (K Units)
Table Johnson and Johnson Company Details
Table Johnson and Johnson Description and Business Overview
Table Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2014-2019)
Table Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Production Market Share in Global Market
Table Johnson and Johnson Recent Development
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK Onychomycosis (Tinea Unguium) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2014-2019)
Table GSK Onychomycosis (Tinea Unguium) Drug Production Market Share in Global Market
Table GSK Recent Development
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Onychomycosis (Tinea Unguium) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2014-2019)
Table Novartis Onychomycosis (Tinea Unguium) Drug Production Market Share in Global Market
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Onychomycosis (Tinea Unguium) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2014-2019)
Table Pfizer Onychomycosis (Tinea Unguium) Drug Production Market Share in Global Market
Table Pfizer Recent Development
Table Valeant Pharma Company Details
Table Valeant Pharma Description and Business Overview
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2014-2019)
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Production Market Share in Global Market
Table Valeant Pharma Recent Development
Table Kaken Pharmaceutical Company Details
Table Kaken Pharmaceutical Description and Business Overview
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2014-2019)
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production Market Share in Global Market
Table Kaken Pharmaceutical Recent Development
Table Galderma Company Details
Table Galderma Description and Business Overview
Table Galderma Onychomycosis (Tinea Unguium) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Galderma Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2014-2019)
Table Galderma Onychomycosis (Tinea Unguium) Drug Production Market Share in Global Market
Table Galderma Recent Development
Table Xiuzheng Pharmaceutical Company Details
Table Xiuzheng Pharmaceutical Description and Business Overview
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Xiuzheng Pharmaceutical Recent Development
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2014-2019)
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production Market Share in Global Market
Table Letai Company Details
Table Letai Description and Business Overview
Table Letai Onychomycosis (Tinea Unguium) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Letai Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2014-2019)
Table Letai Onychomycosis (Tinea Unguium) Drug Production Market Share in Global Market
Table Letai Recent Development
Table Qilu Pharmaceutical Company Details
Table Qilu Pharmaceutical Description and Business Overview
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production Growth Rate (2014-2019)
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production Market Share in Global Market
Table Qilu Pharmaceutical Recent Development
Table Global Onychomycosis (Tinea Unguium) Drug Capacity, Production Forecast 2019-2025 (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Capacity Forecast 2019-2025 (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Forecast 2019-2025 (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Value Forecast 2019-2025 (Million US$)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast 2019-2025 (Million US$)
Table Global Onychomycosis (Tinea Unguium) Drug Production Value Forecast by Regions 2019-2025 (Million US$)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Value Forecast by Regions 2019-2025 (Million US$)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Value Market Share Forecast by Regions 2019-2025
Table Global Onychomycosis (Tinea Unguium) Drug Production Forecast by Regions 2019-2025 (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Forecast by Regions 2019-2025 (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Market Share Forecast by Regions 2019-2025
Table United States Onychomycosis (Tinea Unguium) Drug Production and Value Forecast 2019-2025 (K Units) & (Million US$)
Figure United States Onychomycosis (Tinea Unguium) Drug Production Forecast 2019-2025 (K Units)
Figure United States Onychomycosis (Tinea Unguium) Drug Revenue Forecast 2019-2025 (Million US$)
Table Europe Onychomycosis (Tinea Unguium) Drug Production and Value Forecast 2019-2025 (K Units) & (Million US$)
Figure Europe Onychomycosis (Tinea Unguium) Drug Production Forecast 2019-2025 (K Units)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue Forecast 2019-2025 (Million US$)
Table China Onychomycosis (Tinea Unguium) Drug Production and Value Forecast 2019-2025 (K Units) & (Million US$)
Figure China Onychomycosis (Tinea Unguium) Drug Production Forecast 2019-2025 (K Units)
Figure China Onychomycosis (Tinea Unguium) Drug Revenue Forecast 2019-2025 (Million US$)
Table Japan Onychomycosis (Tinea Unguium) Drug Production and Value Forecast 2019-2025 (K Units) & (Million US$)
Figure Japan Onychomycosis (Tinea Unguium) Drug Production Forecast 2019-2025 (K Units)
Figure Japan Onychomycosis (Tinea Unguium) Drug Revenue Forecast 2019-2025 (Million US$)
Table Global Onychomycosis (Tinea Unguium) Drug Production Forecast by Type 2019-2025 (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Forecast by Type 2019-2025 (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Market Share Forecast by Type 2019-2025
Table Global Onychomycosis (Tinea Unguium) Drug Production Value Forecast by Type 2019-2025 (Million US$)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Value Forecast by Type 2019-2025 (Million US$)
Figure Global Onychomycosis (Tinea Unguium) Drug Production Value Market Share Forecast by Type 2019-2025
Table Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Application 2019-2025 (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Application 2019-2025 (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share Forecast by Application 2019-2025
Table Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share Forecast by Regions 2019-2025
Table North America Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure United States Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Canada Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Mexico Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Table Europe Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure Germany Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure France Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure UK Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Italy Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Russia Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure China Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Japan Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure South Korea Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure India Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Australia Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Indonesia Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Thailand Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Malaysia Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Philippines Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Vietnam Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Table Central & South America Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure Brazil Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure Turkey Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure GCC Countries Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Egypt Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure South Africa Onychomycosis (Tinea Unguium) Drug Consumption Forecast 2019-2025 (K Units)
Figure Onychomycosis (Tinea Unguium) Drug Value Chain
Table Onychomycosis (Tinea Unguium) Drug Distributors List
Table Onychomycosis (Tinea Unguium) Drug Customers List
Table Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の爪真菌症(爪白癬)薬産業:成長傾向・競合分析2019-2025] (Global Onychomycosis (Tinea Unguium) Drug Industry Research Report, Growth Trends and Competitive Analysis 2019-2025 / DATA908B14440)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆